Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
28,272
Sort by:
Scleroderma - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Scleroderma - Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs...
May 2021
100 pages
Global Clinical Trials Market, By Type (Pharmaceutical Trials Vs Medical Device Trials), By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Autoimmune/Inflammation, Oncology, CNS, Diabetes, Cardiovascular, Others), By End User (Clinical Research Organizations, Pharmaceutical and Biotechnological Companies, Clinical Testing Laboratories, Others), By Company, By Region, Forecast & Opportunities, 2026
US$ 4,500.00
Global clinical trials market was valued at USD51.25 billion in 2020 and is anticipated to reach USD77.20 billion by 2026, registering a CAGR of 7.10% in the next five years. The market is driven by t...
May 2021
113 pages
Acute Ischemic Stroke - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Acute Ischemic Stroke – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipel...
May 2021
60 pages
Adenovirus infections - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Adenovirus infections – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipelin...
May 2021
60 pages
Anti-CD20 antibody - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Anti-CD20 antibody – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline...
May 2021
60 pages
Atherosclerosis - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Atherosclerosis – Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companies and 25+ pipeline dr...
May 2021
60 pages
BK Virus infections - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “BK Virus infections – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline...
May 2021
60 pages
Chronic hand eczema - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Chronic hand eczema - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline...
May 2021
60 pages
Gilles de la Tourette’s syndrome
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Gilles de la Tourette’s syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and...
May 2021
60 pages
Lipodystrophy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Lipodystrophy – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drug...
May 2021
60 pages
Methylmalonic academia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Methylmalonic academia - Pipeline Insight, 2021,” report provides comprehensive insights about 6+ companies and 6+ pipeli...
May 2021
60 pages
Middle East respiratory syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Middle East respiratory syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies an...
May 2021
60 pages
Neutropenia - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Neutropenia - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 30+ pipeline drugs...
May 2021
60 pages
Sialorrhoea - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Sialorrhoea – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in...
May 2021
60 pages
Sleep apnoea syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Sleep apnoea syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipel...
May 2021
60 pages
Tendinitis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Tendinitis - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in...
May 2021
60 pages
Vertigo - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Vertigo - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Ver...
May 2021
60 pages
COVID-19 - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “COVID-19 - Pipeline Insight, 2021,” report provides comprehensive insights about 150+ companies and 200+ pipeline drugs i...
May 2021
300 pages
Psoriasis - Pipeline Insight, 2021
US$ 3,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Psoriasis - Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs...
May 2021
200 pages
T cell lymphoma - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “T cell lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 120+ pipeline...
May 2021
200 pages
Brain Metastases - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Brain Metastases – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline d...
May 2021
60 pages
Thymoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Thymoma – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Thy...
May 2021
60 pages
16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021
US$ 3,000.00
16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021 SUMMARY 16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021 provides in depth analysis on 16S Ribosomal RNA (16S rRNA) targeted pipeline...
April 2021
85 pages
23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021
US$ 3,000.00
23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021 SUMMARY 23S Ribosomal RNA (23S rRNA) - Drugs in Development, 2021 provides in depth analysis on 23S Ribosomal RNA (23S rRNA) targeted pipeline...
April 2021
70 pages
Acute Bronchitis (Respiratory) - Drugs in Development, 2021
US$ 2,000.00
Acute Bronchitis (Respiratory) - Drugs in Development, 2021 SUMMARY Acute Bronchitis (Respiratory) - Drugs in Development, 2021 provides an overview of the Acute Bronchitis pipeline landscape. The rep...
April 2021
30 pages
